CompletedInterventionalNot ApplicableLast updated May 1, 2015

Nebivolol in the Supine Hypertension of Autonomic Failure

Effect of Nebivolol on Blood Pressure in a Model of Hypertension Sensitive to Potentiation of Nitric Oxide Bioactivity

Overview

ClinicalTrials.gov ID: NCT01044693
Lead Sponsor: Vanderbilt UniversityOTHER
Brief Summary: The purpose of this study is to evaluate the effect of the antihypertensive drug, nebivolol (Bystolic), compared to metoprolol (Lopressor) and sildenafil (Viagra) on blood pressure in patients with autonomic failure and supine hypertension.
Study Type: Interventional

Status

Study Record Dates

NCT01057251Completed

Nebivolol in Patients With Systolic Stage 2 Hypertension

NCT01056718Completed

Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function

NCT00648895Completed

A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients

NCT00200473Completed

A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients

NCT00200460Completed

A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients

NCT01502787Completed

Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients